Crossmark

Estimating the Public Health and Economic Impact of Introducing the 13-Valent Pneumococcal Conjugate Vaccine or 10-Valent Pneumococcal Conjugate Vaccines into State Immunization Programs in India

Crossref DOI link: https://doi.org/10.1007/s40121-021-00498-4

Published Online: 2021-07-27

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ghia, Canna J. http://orcid.org/0000-0001-9839-3209
Horn, Emily K. http://orcid.org/0000-0002-2491-7134
Rambhad, Gautam

Perdrizet, Johnna http://orcid.org/0000-0002-4260-7607
Chitale, Ramaa http://orcid.org/0000-0002-0984-8433
Wasserman, Matt D. http://orcid.org/0000-0003-3300-2742
Funding

Funding for this research was provided by:

Pfizer
License Information

Text and Data Mining valid from 2021-07-27

Version of Record valid from 2021-07-27
More Information

Article History

Received: 1 May 2021

Accepted: 5 July 2021

First Online: 27 July 2021

Change Date: 8 September 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40121-021-00526-3

Updates are available Correction dated 2021-09-08

Click to view Correction: https://doi.org/10.1007/s40121-021-00526-3